Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028301 · ClinicalTrials.gov registry record · Phase 3
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)
A Phase 3 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00028301: Completed Phase 3 study, sponsored by Bristol-Myers Squibb.
NCT00028301 is a Phase 3 study that has completed, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00028301, a Phase 3 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
This study will compare 2 treatments in the way they affect cholesterol levels and the amount of HIV in the blood.
Interventions
- DRUG Atazanavir
- DRUG Lopinavir/Ritonavir
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-02 |
| Est. Completion | 2003-09 |
| Phase | Phase 3 |
What the finished NCT00028301 record still lists
NCT00028301 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Atazanavir is the first listed.
NCT00028301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00028301 about?
NCT00028301 is a clinical study titled "Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)". This study will compare 2 treatments in the way they affect cholesterol levels and the amount of HIV in the blood.
What is the current status of trial NCT00028301?
This trial is currently completed. It is a Phase 3 study. The study started on 2001-02. Estimated completion is 2003-09.
What interventions are being tested in trial NCT00028301?
The interventions under investigation include: Atazanavir (DRUG), Lopinavir/Ritonavir (DRUG).
Who is sponsoring clinical trial NCT00028301?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia